FYR Diagnostics: Chris Howlett

FYR Diagnostics, a Missoula, Montana-based company focused on using extracellular vesicles to inform disease diagnosis and treatment, has appointed Chris Howlett to its independent board of directors. Howlett most recently served as chairman and CEO of Genelex, leading the company through its sale to Invitae. He also previously worked as senior VP of business development at Unilab, which was eventually acquired by Quest Diagnostics. Howlett also has served as general manager of one of Laboratory Corporation of America's 33 divisional laboratories and spent eight years as regional director of a $900 million business unit. Howlett serves on the boards of DecisionRx and Genomind and is a founding partner and board member of Market Street Healthcare Partners.